首页 > 最新文献

中华预防医学杂志最新文献

英文 中文
[Progress in passive immunization for the prevention of infant respiratory syncytial virus infection]. [被动免疫预防婴儿呼吸道合胞病毒感染的进展]。
Q3 Medicine Pub Date : 2025-10-06 DOI: 10.3760/cma.j.cn112150-20250205-00085
W J Hu, R Z Wang, S B Zhang

Respiratory syncytial virus (RSV) is a common pathogen that causes acute respiratory infections, especially in infants and young children. There are currently no RSV-specific antiviral drugs, and there are no approved vaccines for infants and young children. With the widespread use of RSV passive immunizations in infants and young children in 2022 and the effective reduction of the burden of RSV infection-related diseases, passive immune-prophylaxis of RSV infection has attracted more and more attention. This paper summarizes the implementation experience and real-world application effect of passive immune-prophylaxis for RSV infection at home and abroad, to provide reference for the immune-prophylaxis practice of passive immune-prophylaxis for RSV infection in infants and young children in China.

呼吸道合胞病毒(RSV)是引起急性呼吸道感染的常见病原体,特别是在婴幼儿中。目前还没有针对rsv的抗病毒药物,也没有批准用于婴幼儿的疫苗。随着2022年RSV被动免疫在婴幼儿中的广泛应用,以及RSV感染相关疾病负担的有效减轻,RSV感染的被动免疫预防越来越受到重视。本文总结了国内外被动免疫预防RSV感染的实施经验和实际应用效果,为中国婴幼儿被动免疫预防RSV感染的免疫预防实践提供参考。
{"title":"[Progress in passive immunization for the prevention of infant respiratory syncytial virus infection].","authors":"W J Hu, R Z Wang, S B Zhang","doi":"10.3760/cma.j.cn112150-20250205-00085","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20250205-00085","url":null,"abstract":"<p><p>Respiratory syncytial virus (RSV) is a common pathogen that causes acute respiratory infections, especially in infants and young children. There are currently no RSV-specific antiviral drugs, and there are no approved vaccines for infants and young children. With the widespread use of RSV passive immunizations in infants and young children in 2022 and the effective reduction of the burden of RSV infection-related diseases, passive immune-prophylaxis of RSV infection has attracted more and more attention. This paper summarizes the implementation experience and real-world application effect of passive immune-prophylaxis for RSV infection at home and abroad, to provide reference for the immune-prophylaxis practice of passive immune-prophylaxis for RSV infection in infants and young children in China.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"59 10","pages":"1787-1794"},"PeriodicalIF":0.0,"publicationDate":"2025-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145356158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Machine learning-based predictive model for severe pneumonia in children]. [基于机器学习的儿童重症肺炎预测模型]。
Q3 Medicine Pub Date : 2025-10-06 DOI: 10.3760/cma.j.cn112150-20250126-00076
Q Du, M Z Huang, Y Li, K Chen, L T Hu, C Xiong, X X Lu

Objective: To develop and validate a clinical warning model for severe pediatric community-acquired pneumonia (CAP) using electronic health records. Methods: A retrospective cohort study was conducted, analyzing clinical data of 15 750 children hospitalized for CAP at Wuhan Children's Hospital between January 1, 2019, and December 31, 2023. Patient data were randomly split into training and testing sets at a 7∶3 ratio. Six supervised machine learning models were constructed in the training set, optimized using five-fold cross-validation, and evaluated in the testing set. Model performance was assessed using ROC-AUC, sensitivity, specificity, positive predictive value, negative predictive value, calibration curves, and clinical decision curve analysis at optimal thresholds. The best-performing model was selected, and SHapley Additive exPlanations (SHAP) were used to interpret feature importance. A program interface was developed based on the model results, enabling integration into clinical decision support systems for automated early warning. Results: A total of 15 750 participants, ranging in age from 28 days to 18 years, were included in the study. The median age was 2 years [interquartile range (IQR): 0-4 years], with 9 555 males (60.67%) and 6 195 females (39.33%). Among them, 2 211 (14.04%) developed severe pneumonia. In the prediction models, XGB outperformed other models with an ROC-AUC of 0.884 (95%CI: 0.870-0.898), sensitivity (0.803, 95%CI: 0.772-0.832), specificity (0.828, 95%CI: 0.816-0.839). Calibration analysis showed strong agreement between predicted and observed risks (Brier score: 0.081, 95%CI: 0.075-0.086). The analysis based on the SHAP method revealed that respiratory rate, heart rate, T-lymphocyte subsets, and red blood cell volume distribution width-SD are predictive factors for severe progression of community-acquired pneumonia (CAP) in children. Conclusion: An interpretable machine learning model was developed for the early detection and personalized treatment planning of severe CAP in children, providing valuable support to clinicians.

目的:建立并验证基于电子病历的重症儿童社区获得性肺炎(CAP)临床预警模型。方法:采用回顾性队列研究,分析2019年1月1日至2023年12月31日武汉市儿童医院收治的15750例CAP患儿的临床资料。患者资料按7∶3的比例随机分为训练组和测试组。在训练集中构建了6个有监督机器学习模型,使用五重交叉验证进行了优化,并在测试集中进行了评估。采用ROC-AUC、敏感性、特异性、阳性预测值、阴性预测值、校准曲线和最佳阈值下的临床决策曲线分析来评估模型的性能。选择表现最好的模型,并使用SHapley加性解释(SHAP)来解释特征重要性。基于模型结果开发了一个程序接口,使其能够集成到临床决策支持系统中,实现自动早期预警。结果:共有15750名参与者被纳入研究,年龄从28天到18岁不等。年龄中位数为2岁[四分位间距(IQR): 0 ~ 4岁],其中男性9 555人(60.67%),女性6 195人(39.33%)。其中发生重症肺炎2 211例(14.04%)。在预测模型中,XGB的ROC-AUC为0.884 (95%CI: 0.870-0.898),灵敏度为0.803 (95%CI: 0.772-0.832),特异性为0.828 (95%CI: 0.816-0.839),优于其他模型。校正分析显示预测和观察到的风险高度一致(Brier评分:0.081,95%CI: 0.075-0.086)。基于SHAP方法的分析显示,呼吸频率、心率、t淋巴细胞亚群和红细胞体积分布宽度- sd是儿童社区获得性肺炎(CAP)严重进展的预测因素。结论:建立了一种可解释的机器学习模型,可用于儿童重症CAP的早期发现和个性化治疗计划,为临床医生提供有价值的支持。
{"title":"[Machine learning-based predictive model for severe pneumonia in children].","authors":"Q Du, M Z Huang, Y Li, K Chen, L T Hu, C Xiong, X X Lu","doi":"10.3760/cma.j.cn112150-20250126-00076","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20250126-00076","url":null,"abstract":"<p><p><b>Objective:</b> To develop and validate a clinical warning model for severe pediatric community-acquired pneumonia (CAP) using electronic health records. <b>Methods:</b> A retrospective cohort study was conducted, analyzing clinical data of 15 750 children hospitalized for CAP at Wuhan Children's Hospital between January 1, 2019, and December 31, 2023. Patient data were randomly split into training and testing sets at a 7∶3 ratio. Six supervised machine learning models were constructed in the training set, optimized using five-fold cross-validation, and evaluated in the testing set. Model performance was assessed using ROC-AUC, sensitivity, specificity, positive predictive value, negative predictive value, calibration curves, and clinical decision curve analysis at optimal thresholds. The best-performing model was selected, and SHapley Additive exPlanations (SHAP) were used to interpret feature importance. A program interface was developed based on the model results, enabling integration into clinical decision support systems for automated early warning. <b>Results:</b> A total of 15 750 participants, ranging in age from 28 days to 18 years, were included in the study. The median age was 2 years [interquartile range (IQR): 0-4 years], with 9 555 males (60.67%) and 6 195 females (39.33%). Among them, 2 211 (14.04%) developed severe pneumonia. In the prediction models, XGB outperformed other models with an ROC-AUC of 0.884 (95%<i>CI</i>: 0.870-0.898), sensitivity (0.803, 95%<i>CI</i>: 0.772-0.832), specificity (0.828, 95%<i>CI</i>: 0.816-0.839). Calibration analysis showed strong agreement between predicted and observed risks (Brier score: 0.081, 95%<i>CI</i>: 0.075-0.086). The analysis based on the SHAP method revealed that respiratory rate, heart rate, T-lymphocyte subsets, and red blood cell volume distribution width-SD are predictive factors for severe progression of community-acquired pneumonia (CAP) in children. <b>Conclusion:</b> An interpretable machine learning model was developed for the early detection and personalized treatment planning of severe CAP in children, providing valuable support to clinicians.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"59 10","pages":"1716-1724"},"PeriodicalIF":0.0,"publicationDate":"2025-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145356068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Expert initiative for the prevention and control of human papillomavirus infection and related diseases among Chinese males]. [中国男性人乳头瘤病毒感染及相关疾病防控专家倡议]。
Q3 Medicine Pub Date : 2025-10-06 Epub Date: 2025-08-14 DOI: 10.3760/cma.j.cn112150-20250724-00712

Human papillomavirus (HPV) infection not only causes cervical cancer in women but also leads to HPV-related cancers and genital warts in men. Globally, 82 countries have adopted a gender-neutral HPV vaccination strategy to prevent and control related diseases. In China, HPV vaccination for men has now been implemented. Based on the global and domestic burden of male HPV-related diseases, evidence on the safety and efficacy of HPV vaccines in males, and lessons from international male HPV prevention efforts, a panel of experts has developed the Expert Initiative for the Prevention and Control of HPV Infection and related diseases among Chinese males after multi-round discussions. The initiative proposes: Develop comprehensive strategies for the prevention and control of male HPV infection and related diseases; prioritize and enhance public education and awareness campaigns; promote joint prevention for both men and women and advance gender-inclusive vaccination; innovate financing mechanisms to reduce the economic burden; strengthen research on male HPV infection and vaccination to facilitate the development of new vaccines; and adopt innovative immunization models to improve the quality of vaccination services.

人类乳头瘤病毒(HPV)感染不仅会导致女性患宫颈癌,还会导致男性患与HPV相关的癌症和生殖器疣。在全球,82个国家采用了性别中立的人乳头瘤病毒疫苗接种战略,以预防和控制相关疾病。在中国,现已实施男性HPV疫苗接种。基于全球和国内男性HPV相关疾病的负担,男性HPV疫苗安全性和有效性的证据,以及国际男性HPV预防工作的经验教训,专家小组经过多轮讨论,制定了中国男性HPV感染及相关疾病预防和控制专家倡议。该倡议建议:制定预防和控制男性HPV感染及相关疾病的综合战略;优先考虑并加强公众教育和宣传活动;促进男女联合预防,推进性别包容的疫苗接种;创新融资机制,减轻经济负担;加强对男性HPV感染和疫苗接种的研究,促进新疫苗的开发;采用创新免疫模式,提高预防接种服务质量。
{"title":"[Expert initiative for the prevention and control of human papillomavirus infection and related diseases among Chinese males].","authors":"","doi":"10.3760/cma.j.cn112150-20250724-00712","DOIUrl":"10.3760/cma.j.cn112150-20250724-00712","url":null,"abstract":"<p><p>Human papillomavirus (HPV) infection not only causes cervical cancer in women but also leads to HPV-related cancers and genital warts in men. Globally, 82 countries have adopted a gender-neutral HPV vaccination strategy to prevent and control related diseases. In China, HPV vaccination for men has now been implemented. Based on the global and domestic burden of male HPV-related diseases, evidence on the safety and efficacy of HPV vaccines in males, and lessons from international male HPV prevention efforts, a panel of experts has developed the Expert Initiative for the Prevention and Control of HPV Infection and related diseases among Chinese males after multi-round discussions. The initiative proposes: Develop comprehensive strategies for the prevention and control of male HPV infection and related diseases; prioritize and enhance public education and awareness campaigns; promote joint prevention for both men and women and advance gender-inclusive vaccination; innovate financing mechanisms to reduce the economic burden; strengthen research on male HPV infection and vaccination to facilitate the development of new vaccines; and adopt innovative immunization models to improve the quality of vaccination services.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"59 10","pages":"1611-1619"},"PeriodicalIF":0.0,"publicationDate":"2025-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145356078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Analysis of seroepidemiological characteristics of 11 common respiratory pathogens infection based on 35 665 screened individuals]. [基于35 665例筛查个体的11种常见呼吸道病原体感染血清流行病学特征分析]。
Q3 Medicine Pub Date : 2025-10-06 DOI: 10.3760/cma.j.cn112150-20250225-00135
L Zhang, M F Cao, B Zhang, H L Li, R X Zhang
<p><p><b>Objective:</b> To analyze the seroepidemiological characteristics of common respiratory pathogens in patients screened at a tertiary hospital in Zhangjiakou from 2018 to 2024. <b>Methods:</b> This single-center cross-sectional study utilized data from the laboratory information management system (LIS) of The First Affiliated Hospital of Hebei North University. We collected clinical data and serum-specific IgM antibody test results for 11 common respiratory pathogens (<i>influenza A virus</i>, <i>influenza B virus</i>, <i>respiratory syncytial virus</i>, <i>parainfluenza virus</i>, <i>mycoplasma pneumoniae</i>, <i>chlamydia pneumoniae</i>, <i>legionella pneumophila</i>, <i>coxsackie A virus</i>, <i>coxsackie B virus</i>, <i>echovirus</i> and <i>adenovirus</i>), excluding SARS-CoV-2, from January 1, 2018, to December 31, 2024. Comparative analyses were conducted across three periods: 2018-2019, 2020-2022, and 2023-2024. Statistical analyses were performed using SPSS 26.0, with categorical data presented as percentages and compared using <i>χ</i><sup>2</sup> tests. <b>Results:</b> From 2018 to 2024, a total of 35 665 patients with respiratory tract infection were screened, of which 10 531 were positive for at least one pathogen, with a total positive rate of 29.53% (10 531/35 665). Age-adjusted positive rates were highest in 2023-2024 compared to 2018-2019 and 2020-2022 (<i>χ</i><sup>2</sup>=690.789, <i>P</i><0.001). The specific data are as follows: 21.35% (2 476/11 598) in 2018-2019, 24.35% (2 942/12 081) in 2020-2022, and 35.73% (4 283/11 986) in 2023-2024. Among the 11 pathogens, <i>mycoplasma pneumoniae</i> had the highest overall positivity rate (11.99%, 4 278/35 665), followed by <i>influenza B virus</i> (10.83%, 3 861/35 665), the other nine pathogens showed lower rates (0.88%-4.97%). At different time stages, the positive rates of serum IgM antibodies of various pathogens showed different changing characteristics: in 2023-2024, the positive rates of serum specific IgM antibodies against <i>mycoplasma pneumoniae</i>, <i>influenza B/A virus</i> and <i>adenovirus</i> increased significantly compared with those in 2020-2022, from 10.35%, 11.91%, 3.68%, 0.43% to 12.11%, 14.97%, 5.37%, 4.43% respectively (<i>χ</i><sup>2</sup>=59.150, <i>P</i><0.001; <i>χ</i><sup>2</sup>=579.484, <i>P</i><0.001; <i>χ</i><sup>2</sup>=116.263, <i>P</i><0.001; <i>χ</i><sup>2</sup>=654.125, <i>P</i><0.001). The positive rates of serum IgM antibody in patients of different age groups also showed different changing trends. In 2023-2024, the proportion of people in 18 to 60 and ≥60 age groups increased compared with that in 2018-2019 (<i>χ</i><sup>2</sup>=325.069, <i>P</i><0.001; <i>χ</i><sup>2</sup>=593.612, <i>P</i><0.001), while the 0 to 3, 3 to 6, and 6 to 12 age groups showed declines (<i>χ</i><sup>2</sup>=382.067, <i>P</i><0.001; <i>χ</i><sup>2</sup>=252.835, <i>P</i><0.001; <i>χ</i><sup>2</sup>=285.888, <i>P</i><0.001). Regarding the composition of serum
目的:分析张家口市某三级医院2018 - 2024年筛查患者常见呼吸道病原体的血清流行病学特征。方法:利用河北北方大学第一附属医院实验室信息管理系统(LIS)的数据进行单中心横断面研究。我们收集了2018年1月1日至2024年12月31日期间除SARS-CoV-2外,11种常见呼吸道病原体(甲型流感病毒、乙型流感病毒、呼吸道合胞病毒、副流感病毒、肺炎支原体、肺炎衣原体、嗜肺军团菌、柯萨奇A病毒、柯萨奇B病毒、埃可病毒和腺病毒)的临床资料和血清特异性IgM抗体检测结果。在2018-2019年、2020-2022年和2023-2024年三个时期进行了比较分析。采用SPSS 26.0进行统计分析,分类数据以百分比表示,采用χ2检验进行比较。结果:2018 - 2024年共筛查呼吸道感染患者35 665例,其中至少一种病原菌阳性10 531例,总阳性率为29.53%(10 531/35 665)。与2018-2019年和2020-2022年相比,2023-2024年的年龄校正阳性率最高(χ2=690.789),肺炎支原体总阳性率最高(11.99%,4 278/35 665),其次是乙型流感病毒(10.83%,3 861/35 665),其他9种病原体阳性率较低(0.888 ~ 4.97%)。在不同的时间阶段,各种病原体血清IgM抗体阳性率呈现不同的变化特征:与2020-2022年相比,2023-2024年血清抗肺炎支原体、流感B/A病毒和腺病毒特异性IgM抗体阳性率分别从10.35%、11.91%、3.68%、0.43%显著上升至12.11%、14.97%、5.37%、4.43% (χ2=59.150、Pχ2=579.484、Pχ2=116.263、Pχ2=654.125、Pχ2=325.069、Pχ2=593.612、Pχ2=382.067、Pχ2=252.835、Pχ2=285.888、Pχ2=130.19、Pχ2=65.533、Pχ2=46.836;以甲型流感+乙型流感病毒、乙型流感病毒+肺炎支原体、肺炎支原体+嗜肺军团菌为主。结论:2018 - 2024年,常见呼吸道病原体的血清流行病学特征在不同时间阶段发生显著变化。血清特异性IgM抗体阳性率受社会环境和公共卫生干预措施的影响。血清学检测是本地区呼吸道病原体监测和感染防控的重要手段。
{"title":"[Analysis of seroepidemiological characteristics of 11 common respiratory pathogens infection based on 35 665 screened individuals].","authors":"L Zhang, M F Cao, B Zhang, H L Li, R X Zhang","doi":"10.3760/cma.j.cn112150-20250225-00135","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20250225-00135","url":null,"abstract":"&lt;p&gt;&lt;p&gt;&lt;b&gt;Objective:&lt;/b&gt; To analyze the seroepidemiological characteristics of common respiratory pathogens in patients screened at a tertiary hospital in Zhangjiakou from 2018 to 2024. &lt;b&gt;Methods:&lt;/b&gt; This single-center cross-sectional study utilized data from the laboratory information management system (LIS) of The First Affiliated Hospital of Hebei North University. We collected clinical data and serum-specific IgM antibody test results for 11 common respiratory pathogens (&lt;i&gt;influenza A virus&lt;/i&gt;, &lt;i&gt;influenza B virus&lt;/i&gt;, &lt;i&gt;respiratory syncytial virus&lt;/i&gt;, &lt;i&gt;parainfluenza virus&lt;/i&gt;, &lt;i&gt;mycoplasma pneumoniae&lt;/i&gt;, &lt;i&gt;chlamydia pneumoniae&lt;/i&gt;, &lt;i&gt;legionella pneumophila&lt;/i&gt;, &lt;i&gt;coxsackie A virus&lt;/i&gt;, &lt;i&gt;coxsackie B virus&lt;/i&gt;, &lt;i&gt;echovirus&lt;/i&gt; and &lt;i&gt;adenovirus&lt;/i&gt;), excluding SARS-CoV-2, from January 1, 2018, to December 31, 2024. Comparative analyses were conducted across three periods: 2018-2019, 2020-2022, and 2023-2024. Statistical analyses were performed using SPSS 26.0, with categorical data presented as percentages and compared using &lt;i&gt;χ&lt;/i&gt;&lt;sup&gt;2&lt;/sup&gt; tests. &lt;b&gt;Results:&lt;/b&gt; From 2018 to 2024, a total of 35 665 patients with respiratory tract infection were screened, of which 10 531 were positive for at least one pathogen, with a total positive rate of 29.53% (10 531/35 665). Age-adjusted positive rates were highest in 2023-2024 compared to 2018-2019 and 2020-2022 (&lt;i&gt;χ&lt;/i&gt;&lt;sup&gt;2&lt;/sup&gt;=690.789, &lt;i&gt;P&lt;/i&gt;&lt;0.001). The specific data are as follows: 21.35% (2 476/11 598) in 2018-2019, 24.35% (2 942/12 081) in 2020-2022, and 35.73% (4 283/11 986) in 2023-2024. Among the 11 pathogens, &lt;i&gt;mycoplasma pneumoniae&lt;/i&gt; had the highest overall positivity rate (11.99%, 4 278/35 665), followed by &lt;i&gt;influenza B virus&lt;/i&gt; (10.83%, 3 861/35 665), the other nine pathogens showed lower rates (0.88%-4.97%). At different time stages, the positive rates of serum IgM antibodies of various pathogens showed different changing characteristics: in 2023-2024, the positive rates of serum specific IgM antibodies against &lt;i&gt;mycoplasma pneumoniae&lt;/i&gt;, &lt;i&gt;influenza B/A virus&lt;/i&gt; and &lt;i&gt;adenovirus&lt;/i&gt; increased significantly compared with those in 2020-2022, from 10.35%, 11.91%, 3.68%, 0.43% to 12.11%, 14.97%, 5.37%, 4.43% respectively (&lt;i&gt;χ&lt;/i&gt;&lt;sup&gt;2&lt;/sup&gt;=59.150, &lt;i&gt;P&lt;/i&gt;&lt;0.001; &lt;i&gt;χ&lt;/i&gt;&lt;sup&gt;2&lt;/sup&gt;=579.484, &lt;i&gt;P&lt;/i&gt;&lt;0.001; &lt;i&gt;χ&lt;/i&gt;&lt;sup&gt;2&lt;/sup&gt;=116.263, &lt;i&gt;P&lt;/i&gt;&lt;0.001; &lt;i&gt;χ&lt;/i&gt;&lt;sup&gt;2&lt;/sup&gt;=654.125, &lt;i&gt;P&lt;/i&gt;&lt;0.001). The positive rates of serum IgM antibody in patients of different age groups also showed different changing trends. In 2023-2024, the proportion of people in 18 to 60 and ≥60 age groups increased compared with that in 2018-2019 (&lt;i&gt;χ&lt;/i&gt;&lt;sup&gt;2&lt;/sup&gt;=325.069, &lt;i&gt;P&lt;/i&gt;&lt;0.001; &lt;i&gt;χ&lt;/i&gt;&lt;sup&gt;2&lt;/sup&gt;=593.612, &lt;i&gt;P&lt;/i&gt;&lt;0.001), while the 0 to 3, 3 to 6, and 6 to 12 age groups showed declines (&lt;i&gt;χ&lt;/i&gt;&lt;sup&gt;2&lt;/sup&gt;=382.067, &lt;i&gt;P&lt;/i&gt;&lt;0.001; &lt;i&gt;χ&lt;/i&gt;&lt;sup&gt;2&lt;/sup&gt;=252.835, &lt;i&gt;P&lt;/i&gt;&lt;0.001; &lt;i&gt;χ&lt;/i&gt;&lt;sup&gt;2&lt;/sup&gt;=285.888, &lt;i&gt;P&lt;/i&gt;&lt;0.001). Regarding the composition of serum ","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"59 10","pages":"1676-1684"},"PeriodicalIF":0.0,"publicationDate":"2025-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145356297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Application of three-dimensional U-shaped residual coordinated attention network in early detection of small intestinal polyps]. [三维u型残留协调注意网络在小肠息肉早期发现中的应用]。
Q3 Medicine Pub Date : 2025-10-06 DOI: 10.3760/cma.j.cn112150-20241105-00878
Z J Gao, X F Zhang, X Chen, X S Li, X M Liu

Objective: To establish a three-dimensional U-shaped residual coordinated attention network (URCA-Net) based on enhanced CT images for small bowel polyp detection and analyze its application effectiveness in intelligent detection of small bowel polyps. Methods: Abdominal CT data of patients with small bowel polyps were collected from the Air Force Medical Center between June 2019 and July 2023. All patients underwent bowel preparation followed by thin-slice spiral CT scanning to obtain enhanced CT arterial phase images. The data were randomly divided into training, validation and test sets in an 8∶1∶1 ratio. The URCA-Net deep learning model was used for small bowel polyp segmentation. The training set was used for model parameter training, the validation set for hyperparameter adjustment and monitoring of model generalization performance and the test set for final unbiased evaluation of the model. An early intelligent detection model for small bowel polyps was constructed, and its performance was evaluated. Evaluation metrics included pixel-level metrics for the segmentation task [Dice Similarity Coefficient (DSC)], as well as sensitivity and precision for polyp detection. A two-stage segmentation strategy was adopted: the first stage segmented the small bowel region to remove external interference, and the second stage performed polyp segmentation within the small bowel region. Results: A total of 78 subjects were included in the study, with an average age of (54±7) years. A total of 23 400 scan images were extracted, including 136 hyperplastic polyps, 298 hamartomatous polyps, 14 adenomatous polyps, and 4 cancerous polyps. On the test set, the average DSC for the first stage (small bowel segmentation) and the second stage (polyp segmentation) was 0.790 and 0.314, respectively. In the second stage task (polyp segmentation based on small bowel region), the polyp segmentation DSC increased to 0.701, with a precision of 0.836 (95%CI: 0.700-0.972) and a sensitivity of 0.759 (95%CI: 0.631-0.888) for polyp detection. Conclusion: The URCA-Net deep learning technique demonstrates good auxiliary diagnostic effectiveness in small bowel polyp detection and can provide a reference for screening and detection of small bowel polyps. The model is capable of generating high-quality segmentation results, which could facilitate evaluating polyp lesion morphology and provide support for downstream tasks such as preoperative navigation and risk prediction.

目的:建立基于增强CT图像的三维u型剩余协调注意网络(URCA-Net)用于小肠息肉检测,并分析其在小肠息肉智能检测中的应用效果。方法:收集空军医学中心2019年6月至2023年7月小肠息肉患者的腹部CT资料。所有患者都进行了肠道准备,然后进行了薄层螺旋CT扫描,以获得增强的CT动脉期图像。数据按8∶1∶1的比例随机分为训练集、验证集和测试集。采用URCA-Net深度学习模型对小肠息肉进行分割。训练集用于模型参数训练,验证集用于超参数调整和模型泛化性能监控,测试集用于模型的最终无偏评价。建立了小肠息肉早期智能检测模型,并对其性能进行了评价。评估指标包括分割任务的像素级指标[骰子相似系数(DSC)],以及息肉检测的灵敏度和精度。采用两阶段分割策略,第一阶段对小肠区域进行分割去除外界干扰,第二阶段对小肠区域内息肉进行分割。结果:共纳入受试者78例,平均年龄(54±7)岁。共提取扫描图像23 400张,其中增生性息肉136张,错构瘤性息肉298张,腺瘤性息肉14张,癌性息肉4张。在测试集上,第一阶段(小肠分割)和第二阶段(息肉分割)的平均DSC分别为0.790和0.314。在第二阶段任务(基于小肠区域的息肉分割)中,息肉分割DSC提高到0.701,检测息肉的精度为0.836 (95%CI: 0.700 ~ 0.972),灵敏度为0.759 (95%CI: 0.631 ~ 0.888)。结论:URCA-Net深度学习技术在小肠息肉检测中具有良好的辅助诊断效果,可为小肠息肉的筛查和检测提供参考。该模型能够生成高质量的分割结果,便于对息肉病变形态进行评估,为术前导航、风险预测等下游任务提供支持。
{"title":"[Application of three-dimensional U-shaped residual coordinated attention network in early detection of small intestinal polyps].","authors":"Z J Gao, X F Zhang, X Chen, X S Li, X M Liu","doi":"10.3760/cma.j.cn112150-20241105-00878","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20241105-00878","url":null,"abstract":"<p><p><b>Objective:</b> To establish a three-dimensional U-shaped residual coordinated attention network (URCA-Net) based on enhanced CT images for small bowel polyp detection and analyze its application effectiveness in intelligent detection of small bowel polyps. <b>Methods:</b> Abdominal CT data of patients with small bowel polyps were collected from the Air Force Medical Center between June 2019 and July 2023. All patients underwent bowel preparation followed by thin-slice spiral CT scanning to obtain enhanced CT arterial phase images. The data were randomly divided into training, validation and test sets in an 8∶1∶1 ratio. The URCA-Net deep learning model was used for small bowel polyp segmentation. The training set was used for model parameter training, the validation set for hyperparameter adjustment and monitoring of model generalization performance and the test set for final unbiased evaluation of the model. An early intelligent detection model for small bowel polyps was constructed, and its performance was evaluated. Evaluation metrics included pixel-level metrics for the segmentation task [Dice Similarity Coefficient (DSC)], as well as sensitivity and precision for polyp detection. A two-stage segmentation strategy was adopted: the first stage segmented the small bowel region to remove external interference, and the second stage performed polyp segmentation within the small bowel region. <b>Results:</b> A total of 78 subjects were included in the study, with an average age of (54±7) years. A total of 23 400 scan images were extracted, including 136 hyperplastic polyps, 298 hamartomatous polyps, 14 adenomatous polyps, and 4 cancerous polyps. On the test set, the average DSC for the first stage (small bowel segmentation) and the second stage (polyp segmentation) was 0.790 and 0.314, respectively. In the second stage task (polyp segmentation based on small bowel region), the polyp segmentation DSC increased to 0.701, with a precision of 0.836 (95%<i>CI</i>: 0.700-0.972) and a sensitivity of 0.759 (95%<i>CI</i>: 0.631-0.888) for polyp detection. <b>Conclusion:</b> The URCA-Net deep learning technique demonstrates good auxiliary diagnostic effectiveness in small bowel polyp detection and can provide a reference for screening and detection of small bowel polyps. The model is capable of generating high-quality segmentation results, which could facilitate evaluating polyp lesion morphology and provide support for downstream tasks such as preoperative navigation and risk prediction.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"59 10","pages":"1756-1762"},"PeriodicalIF":0.0,"publicationDate":"2025-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145356321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Mechanisms, prevention and treatment strategies of cat allergen sensitization]. 【猫过敏原致敏的机制、防治策略】。
Q3 Medicine Pub Date : 2025-09-06 DOI: 10.3760/cma.j.cn112150-20250416-00321
Y B Chen, L Jiang, M Zhang

Cat allergens are among the most significant environmental factors contributing to the onset of allergic diseases. The increasing global prevalence of pet cat ownership in recent years has been associated with a rise in the incidence of allergic diseases linked to cat allergens. Research has demonstrated that pet cats can trigger type I hypersensitivity-related conditions, such as allergic rhinitis, asthma, and atopic dermatitis, in atopic individuals through allergens found in their dander, saliva, urine, and other substances. The precise mechanism by which cat allergens induce immune tolerance remains incompletely understood. Furthermore, due to the complexities of multiple sensitizations and cross-reactivity, the interactions between cat allergens and other pet allergens (e.g., dog allergens) and air pollutants in the development of allergic diseases are not yet fully elucidated. Consequently, this article reviews recent advancements in the epidemiology of cat allergen sensitization, the underlying mechanisms, exposure and sensitization risks, component-resolved diagnostics, treatment, and prevention, with the aim of providing references for clinical strategies in the prevention, diagnosis, and management of these conditions.

猫过敏原是导致过敏性疾病发生的最重要的环境因素之一。近年来,全球越来越多的人拥有宠物猫,这与猫过敏原相关的过敏性疾病的发病率上升有关。研究表明,宠物猫可以通过皮屑、唾液、尿液和其他物质中的过敏原,引发I型超敏反应相关疾病,如过敏性鼻炎、哮喘和特应性皮炎。猫过敏原诱导免疫耐受的确切机制尚不完全清楚。此外,由于多重致敏和交叉反应的复杂性,猫过敏原与其他宠物过敏原(如狗过敏原)和空气污染物之间的相互作用在过敏性疾病的发展中尚未完全阐明。因此,本文综述了猫过敏原致敏的流行病学、潜在机制、暴露和致敏风险、成分分解诊断、治疗和预防方面的最新进展,旨在为预防、诊断和管理这些疾病的临床策略提供参考。
{"title":"[Mechanisms, prevention and treatment strategies of cat allergen sensitization].","authors":"Y B Chen, L Jiang, M Zhang","doi":"10.3760/cma.j.cn112150-20250416-00321","DOIUrl":"10.3760/cma.j.cn112150-20250416-00321","url":null,"abstract":"<p><p>Cat allergens are among the most significant environmental factors contributing to the onset of allergic diseases. The increasing global prevalence of pet cat ownership in recent years has been associated with a rise in the incidence of allergic diseases linked to cat allergens. Research has demonstrated that pet cats can trigger type I hypersensitivity-related conditions, such as allergic rhinitis, asthma, and atopic dermatitis, in atopic individuals through allergens found in their dander, saliva, urine, and other substances. The precise mechanism by which cat allergens induce immune tolerance remains incompletely understood. Furthermore, due to the complexities of multiple sensitizations and cross-reactivity, the interactions between cat allergens and other pet allergens (e.g., dog allergens) and air pollutants in the development of allergic diseases are not yet fully elucidated. Consequently, this article reviews recent advancements in the epidemiology of cat allergen sensitization, the underlying mechanisms, exposure and sensitization risks, component-resolved diagnostics, treatment, and prevention, with the aim of providing references for clinical strategies in the prevention, diagnosis, and management of these conditions.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"59 9","pages":"1372-1380"},"PeriodicalIF":0.0,"publicationDate":"2025-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145070672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Analysis of the drug resistence and the whole genome characteristics of mycoplasma pneumoniae strains in Suzhou City from 2023 to 2024]. [2023 - 2024年苏州市肺炎支原体耐药及全基因组特征分析]。
Q3 Medicine Pub Date : 2025-09-06 DOI: 10.3760/cma.j.cn112150-20250107-00016
M Yuan, X L Wang, Q Shen, X R Ya, X Yuan, G Tian, Z F Dong

To analyze the prevalence, drug resistance and whole genome characteristics of Mycoplasma pneumoniae (MP) in respiratory throat swab samples of hospitalized children with pneumonia in Suzhou City from 2023 to 2024. Throat swab samples of hospitalized children aged 0-14 years old with pneumonia in Suzhou were collected from September 2023 to September 2024. Real-time fluorenscence quantitative PCR technology was used to detect MP nucleic acid. The results showed that the positive rate of MP in 3 235 samples was 22.44% (726/3 235), with a rate of 55.00% in week 47 of 2023. The positive rate of MP increased with age (χ2=45.842, P<0.001). The study selected MP nucleic acid test positive samples from week 20 (5.13-5.19) to week 23 (6.3-6.9) of 2024 for isolation, culture and resistance phenotype detection. About 31 MP strains were successfully isolated and cultured, all of which were resistant to macrolides. The next-generation sequencing technology and nanopore sequencing technology were used for genome sequencing. All 31 strains carried the A2063G mutation, with the main prevalent genotype being the P1-1, and the main mlST type being the ST3. Despite the overall genomic similarity between strains being over 99%, there were significant differences between the P1-1 and P1-2 strains in the P1 gene region. In summary, from 2023 to 2024, the main MP type prevalent in Suzhou City is the P1-1 genotype. All isolated MP strains carry an A2063G resistance site mutation and are resistant to macrolides, requiring continuous monitoring and further research.

目的分析苏州市2023 - 2024年住院肺炎患儿呼吸道咽拭子中肺炎支原体(Mycoplasma pneumoniae, MP)的流行情况、耐药性及全基因组特征。收集苏州市2023年9月至2024年9月住院的0 ~ 14岁肺炎患儿咽拭子样本。采用实时荧光定量PCR技术检测MP核酸。结果3 235份标本MP阳性率为22.44%(726/3 235),2023年第47周阳性率为55.00%。MP阳性率随年龄增加而增加(χ2=45.842, P0.001)。本研究选取2024年第20周(5.13-5.19)至第23周(6.3-6.9)MP核酸检测阳性样本进行分离、培养和抗性表型检测。成功分离培养了31株MP菌株,均对大环内酯类耐药。基因组测序采用新一代测序技术和纳米孔测序技术。31株均携带A2063G突变,主要流行基因型为P1-1,主要mlST型为ST3。尽管菌株间总体基因组相似性超过99%,但P1-1和P1-2菌株在P1基因区域存在显著差异。综上所述,2023 - 2024年苏州市流行的主要MP型为P1-1基因型。所有分离的MP菌株都携带A2063G耐药位点突变,对大环内酯类耐药,需要持续监测和进一步研究。
{"title":"[Analysis of the drug resistence and the whole genome characteristics of mycoplasma pneumoniae strains in Suzhou City from 2023 to 2024].","authors":"M Yuan, X L Wang, Q Shen, X R Ya, X Yuan, G Tian, Z F Dong","doi":"10.3760/cma.j.cn112150-20250107-00016","DOIUrl":"10.3760/cma.j.cn112150-20250107-00016","url":null,"abstract":"<p><p>To analyze the prevalence, drug resistance and whole genome characteristics of <i>Mycoplasma pneumoniae</i> (MP) in respiratory throat swab samples of hospitalized children with pneumonia in Suzhou City from 2023 to 2024. Throat swab samples of hospitalized children aged 0-14 years old with pneumonia in Suzhou were collected from September 2023 to September 2024. Real-time fluorenscence quantitative PCR technology was used to detect MP nucleic acid. The results showed that the positive rate of MP in 3 235 samples was 22.44% (726/3 235), with a rate of 55.00% in week 47 of 2023. The positive rate of MP increased with age (<i>χ</i><sup>2</sup>=45.842, <i>P<</i>0.001). The study selected MP nucleic acid test positive samples from week 20 (5.13-5.19) to week 23 (6.3-6.9) of 2024 for isolation, culture and resistance phenotype detection. About 31 MP strains were successfully isolated and cultured, all of which were resistant to macrolides. The next-generation sequencing technology and nanopore sequencing technology were used for genome sequencing. All 31 strains carried the A2063G mutation, with the main prevalent genotype being the P1-1, and the main mlST type being the ST3. Despite the overall genomic similarity between strains being over 99%, there were significant differences between the P1-1 and P1-2 strains in the P1 gene region. In summary, from 2023 to 2024, the main MP type prevalent in Suzhou City is the P1-1 genotype. All isolated MP strains carry an A2063G resistance site mutation and are resistant to macrolides, requiring continuous monitoring and further research.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"59 9","pages":"1533-1539"},"PeriodicalIF":0.0,"publicationDate":"2025-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145070817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Allergic profile characteristics and clinical application trends in patients undergoing immunotherapy for cat and dog hair allergens: a retrospective analysis from 2019 to 2023]. 【2019 - 2023年猫、狗毛发过敏原免疫治疗患者的过敏特征及临床应用趋势:回顾性分析】。
Q3 Medicine Pub Date : 2025-09-06 DOI: 10.3760/cma.j.cn112150-20250124-00073
Q Wang, L S Li, Y Wang, J Yin, J Q Gu, J Zheng, Y Li, Z R Du, K Guan

Objective: To investigate the clinical demand for subcutaneous immunotherapy (SCIT) with pet allergens and explore the sensitization characteristics of patients undergoing pet SCIT. Methods: A cross-sectional retrospective analysis was conducted on patients diagnosed with pet allergies and treated with pet allergen SCIT in our outpatient clinic from January 2019 to December 2023. Patients were categorized into three groups based on the type of SCIT received: single-cat SCIT group, single-dog SCIT group, and combined cat-dog SCIT group. Results: A total of 931 patients were included, the age range was 5-65 years (median age of 30 years), with 283 male and 648 female. Among them, 67.7%(n=630) received single-cat SCIT, 10.9% (n=102)received single-dog SCIT, and 21.4% (n=199) received combined cat-dog SCIT. The number of patients receiving pet allergen SCIT increased annually. Patients in the single-dog SCIT group were significantly older than those in the other two groups (H=41.329,P<0.001) and had a lower prevalence of allergic rhinitis (91.2% vs. 96.5% and 98.5%; χ2=10.400,P=0.006). In the combined cat-dog SCIT group, the allergy rate to mold allergens was significantly higher than in the single-cat SCIT group (12.6% vs. 4.9%, χ2=13.965,P=0.001). In the single-dog SCIT group, the allergy rate to spring pollen allergens was significantly higher than in the other two groups (χ2=15.731,P<0.001), and the allergy rate to autumn pollen allergens was significantly higher than in the single-cat SCIT group (χ2=13.459,P=0.001). There was no significant difference in the dust mite allergy rate among the three groups(χ2=4.117,P=0.129). In the single-dog SCIT group, patients with asthma were significantly older than those without asthma (41.2 vs. 35.2 years old,t=-2.073,P=0.041). In both the single-cat and single-dog SCIT groups, the proportion of allergic rhinitis in the asthma group(91.2%,78.3%) was significantly lower than that in the non-asthma group(97.4%,94.9%) (χ2=8.863,6.158;P=0.008,0.026). In the single-cat SCIT group, non-asthmatic patients were significantly more likely to receive SCIT combined with spring pollen allergens compared to asthmatic patients (23.9% vs. 11.0%, χ2=7.586,P=0.006). Conclusions: The demand for pet allergen SCIT has steadily increased over the years, with a predominance of female patients. Sensitization profiles varied among patients receiving SCIT for different pet allergens. This study comprehensively elucidates the clinical demand and sensitization characteristics of patients undergoing pet allergen SCIT, providing valuable reference data for clinical diagnosis and treatment.

目的:了解宠物致敏原皮下免疫治疗(SCIT)的临床需求,探讨宠物皮下免疫治疗患者的致敏特点。方法:对2019年1月至2023年12月我院门诊诊断为宠物过敏并使用宠物过敏原SCIT治疗的患者进行横断面回顾性分析。根据接受的SCIT类型,将患者分为三组:单猫SCIT组、单狗SCIT组和猫狗联合SCIT组。结果:共纳入931例患者,年龄5 ~ 65岁,中位年龄30岁,其中男性283例,女性648例。其中67.7%(n=630)接受单猫SCIT, 10.9% (n=102)接受单狗SCIT, 21.4% (n=199)接受猫狗联合SCIT。接受宠物过敏原SCIT治疗的患者数量逐年增加。单犬SCIT组患者年龄明显高于其他两组(H=41.329, p < 0.05)。96.5%和98.5%;χ2 = 10.400,P = 0.006)。猫狗联合SCIT组对霉菌过敏原的过敏率显著高于单猫SCIT组(12.6% vs. 4.9%, χ2=13.965,P=0.001)。单犬SCIT组对春花粉过敏原的过敏率显著高于其他两组(χ2=15.731,Pχ2=13.459,P=0.001)。三组间尘螨过敏率差异无统计学意义(χ2=4.117,P=0.129)。在单犬SCIT组中,哮喘患者的年龄明显大于无哮喘患者(41.2岁vs 35.2岁,t=-2.073,P=0.041)。在单猫、单狗SCIT组中,哮喘组变应性鼻炎患病率(91.2%、78.3%)均显著低于非哮喘组(97.4%、94.9%)(χ2=8.863、6.158;P=0.008、0.026)。在单猫SCIT组中,与哮喘患者相比,非哮喘患者接受SCIT合并春季花粉过敏原的可能性显著高于哮喘患者(23.9%比11.0%,χ2=7.586,P=0.006)。结论:近年来,宠物过敏原SCIT的需求稳步增长,且以女性患者为主。接受SCIT治疗的患者对不同宠物过敏原的致敏情况各不相同。本研究全面阐述了宠物过敏原SCIT患者的临床需求和致敏特点,为临床诊断和治疗提供了有价值的参考数据。
{"title":"[Allergic profile characteristics and clinical application trends in patients undergoing immunotherapy for cat and dog hair allergens: a retrospective analysis from 2019 to 2023].","authors":"Q Wang, L S Li, Y Wang, J Yin, J Q Gu, J Zheng, Y Li, Z R Du, K Guan","doi":"10.3760/cma.j.cn112150-20250124-00073","DOIUrl":"10.3760/cma.j.cn112150-20250124-00073","url":null,"abstract":"<p><p><b>Objective:</b> To investigate the clinical demand for subcutaneous immunotherapy (SCIT) with pet allergens and explore the sensitization characteristics of patients undergoing pet SCIT. <b>Methods:</b> A cross-sectional retrospective analysis was conducted on patients diagnosed with pet allergies and treated with pet allergen SCIT in our outpatient clinic from January 2019 to December 2023. Patients were categorized into three groups based on the type of SCIT received: single-cat SCIT group, single-dog SCIT group, and combined cat-dog SCIT group. <b>Results:</b> A total of 931 patients were included, the age range was 5-65 years (median age of 30 years), with 283 male and 648 female. Among them, 67.7%(<i>n</i>=630) received single-cat SCIT, 10.9% (<i>n</i>=102)received single-dog SCIT, and 21.4% (<i>n</i>=199) received combined cat-dog SCIT. The number of patients receiving pet allergen SCIT increased annually. Patients in the single-dog SCIT group were significantly older than those in the other two groups (<i>H</i>=41.329,<i>P</i><0.001) and had a lower prevalence of allergic rhinitis (91.2% <i>vs.</i> 96.5% and 98.5%; <i>χ</i><sup>2</sup>=10.400,<i>P</i>=0.006). In the combined cat-dog SCIT group, the allergy rate to mold allergens was significantly higher than in the single-cat SCIT group (12.6% <i>vs.</i> 4.9%, <i>χ</i><sup>2</sup>=13.965,<i>P</i>=0.001). In the single-dog SCIT group, the allergy rate to spring pollen allergens was significantly higher than in the other two groups (<i>χ</i><sup>2</sup>=15.731,<i>P</i><0.001), and the allergy rate to autumn pollen allergens was significantly higher than in the single-cat SCIT group (<i>χ</i><sup>2</sup>=13.459,<i>P</i>=0.001). There was no significant difference in the dust mite allergy rate among the three groups(<i>χ</i><sup>2</sup>=4.117,<i>P</i>=0.129). In the single-dog SCIT group, patients with asthma were significantly older than those without asthma (41.2 <i>vs.</i> 35.2 years old,<i>t</i>=-2.073,<i>P</i>=0.041). In both the single-cat and single-dog SCIT groups, the proportion of allergic rhinitis in the asthma group(91.2%,78.3%) was significantly lower than that in the non-asthma group(97.4%,94.9%) (<i>χ</i><sup>2</sup>=8.863,6.158;<i>P</i>=0.008,0.026). In the single-cat SCIT group, non-asthmatic patients were significantly more likely to receive SCIT combined with spring pollen allergens compared to asthmatic patients (23.9% <i>vs.</i> 11.0%, <i>χ</i><sup>2</sup>=7.586,<i>P</i>=0.006). <b>Conclusions:</b> The demand for pet allergen SCIT has steadily increased over the years, with a predominance of female patients. Sensitization profiles varied among patients receiving SCIT for different pet allergens. This study comprehensively elucidates the clinical demand and sensitization characteristics of patients undergoing pet allergen SCIT, providing valuable reference data for clinical diagnosis and treatment.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"59 9","pages":"1407-1413"},"PeriodicalIF":0.0,"publicationDate":"2025-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145070820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Expert recommendations on the development content and functional specifications for the public vaccination service platform]. 【关于公众预防接种服务平台开发内容和功能规范的专家建议】。
Q3 Medicine Pub Date : 2025-09-06 DOI: 10.3760/cma.j.cn112150-20250609-00527
Q Zhu, Q L Ma, R L Xie, L J Liu, L Li, L Chen, Y Huang, R H Tan, X R Cai, J F He, W Z Yu

To satisfy the growing healthcare demands of the public, it is essential to develop a public service platform for vaccination. This initiative aligns with national policies, optimizes resource allocation, innovates service models, enhances service efficiency, and reduces service costs. Drawing on relevant national policies and regulatory requirements, as well as the notable achievements and practical experiences gained through the exploration and innovation of vaccination service models across various regions, this paper proposes expert recommendations. It defines the essential components and functional specifications for public service platforms, focusing on public needs such as electronic vaccination record management, appointment management, the promotion of electronic vaccination certificates, vaccination certificate verification for school enrollment, vaccination site navigation, and science communication and public engagement. The recommendations aim to serve as a reference for the development of vaccination public service platforms nationwide.

为满足公众日益增长的卫生保健需求,建立预防接种公共服务平台势在必行。“一带一路”倡议契合国家政策,优化资源配置,创新服务模式,提高服务效率,降低服务成本。结合国家相关政策和监管要求,结合各地探索创新疫苗接种服务模式取得的显著成果和实践经验,提出专家建议。明确了公共服务平台的基本组成部分和功能规范,重点围绕电子预防接种记录管理、预约管理、推广电子预防接种证书、学校入学预防接种证书核查、预防接种网站导航、科学传播和公众参与等公众需求。这些建议旨在为全国疫苗接种公共服务平台的发展提供参考。
{"title":"[Expert recommendations on the development content and functional specifications for the public vaccination service platform].","authors":"Q Zhu, Q L Ma, R L Xie, L J Liu, L Li, L Chen, Y Huang, R H Tan, X R Cai, J F He, W Z Yu","doi":"10.3760/cma.j.cn112150-20250609-00527","DOIUrl":"10.3760/cma.j.cn112150-20250609-00527","url":null,"abstract":"<p><p>To satisfy the growing healthcare demands of the public, it is essential to develop a public service platform for vaccination. This initiative aligns with national policies, optimizes resource allocation, innovates service models, enhances service efficiency, and reduces service costs. Drawing on relevant national policies and regulatory requirements, as well as the notable achievements and practical experiences gained through the exploration and innovation of vaccination service models across various regions, this paper proposes expert recommendations. It defines the essential components and functional specifications for public service platforms, focusing on public needs such as electronic vaccination record management, appointment management, the promotion of electronic vaccination certificates, vaccination certificate verification for school enrollment, vaccination site navigation, and science communication and public engagement. The recommendations aim to serve as a reference for the development of vaccination public service platforms nationwide.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"59 9","pages":"1448-1453"},"PeriodicalIF":0.0,"publicationDate":"2025-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145070299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The role and research progress of vitamin D in skin aging]. [维生素D在皮肤衰老中的作用及研究进展]。
Q3 Medicine Pub Date : 2025-09-06 DOI: 10.3760/cma.j.cn112150-20250215-00110
H Bai, M Wang, S S Zhao, Y Yan

Skin aging is a complex physiological process that is associated with various skin diseases and affects appearance.Vitamin D, a fat-soluble vitamin synthesized after exposure of the skin to ultraviolet B radiation, has been found to regulate skin aging by modulating the physiological functions of skin cells, regulating the immune system, inducing antioxidative responses, inhibiting DNA damage, and promoting its repair. This article elucidates the multi-target mechanism of vitamin D in delaying skin aging, providing a new theoretical foundation for preventive medicine to retard aging and related diseases through nutritional intervention.

皮肤老化是一个复杂的生理过程,与各种皮肤疾病有关,并影响外观。维生素D是一种脂溶性维生素,在皮肤暴露于紫外线B辐射后合成,已被发现通过调节皮肤细胞的生理功能、调节免疫系统、诱导抗氧化反应、抑制DNA损伤和促进其修复来调节皮肤老化。本文阐明了维生素D延缓皮肤衰老的多靶点机制,为预防医学通过营养干预延缓衰老及相关疾病提供新的理论基础。
{"title":"[The role and research progress of vitamin D in skin aging].","authors":"H Bai, M Wang, S S Zhao, Y Yan","doi":"10.3760/cma.j.cn112150-20250215-00110","DOIUrl":"10.3760/cma.j.cn112150-20250215-00110","url":null,"abstract":"<p><p>Skin aging is a complex physiological process that is associated with various skin diseases and affects appearance.Vitamin D, a fat-soluble vitamin synthesized after exposure of the skin to ultraviolet B radiation, has been found to regulate skin aging by modulating the physiological functions of skin cells, regulating the immune system, inducing antioxidative responses, inhibiting DNA damage, and promoting its repair. This article elucidates the multi-target mechanism of vitamin D in delaying skin aging, providing a new theoretical foundation for preventive medicine to retard aging and related diseases through nutritional intervention.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"59 9","pages":"1584-1589"},"PeriodicalIF":0.0,"publicationDate":"2025-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145070710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中华预防医学杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1